the-infoshop.com - The vertical markets research portal

View Cart

Global Information, Inc.
US:	+1-860-674-8796
EU:	+32-2-535-7543
SG:	+65-6223-2436

|

|

|

Custom Research

|

About The Infoshop

|

|

|

Bone Disease Treatment

Feminine Hygiene

Gastrointestinal

In Vitro Diagnostics(IVD)

Infection Disease

Neurodegenerative Disease

Obesity Treatment

Pharmaceutical Companies

Prescription Drugs

Therapeutics / Diagnosis

Veterinary Medicine

View All Categories

[Report]

Intravenous Solutions - A MARKET INSIGHT REPORT

Published: 2008/03

Contact 24 hrs/day

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Introduction
- History
- Definitions
- Intravenous
- Intravenous Infusion
- Parenteral
- Enteral
- Home Parenteral Nutrition (HPN)
- Partial Parenteral Nutrition (PPN)
- Total Parenteral Nutrition (TPN)
- Benefits
- Hazards of Intravenous Feeding
- Segmentation of Intravenous Solutions
  - Exhibit 1: Segmentation of Intravenous Solutions Market by Type (Partial Parenteral Nutrition and Total Parenteral Nutrition) and Nutrients (Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other)
2. Global Market Analysis
- Exhibit 2: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) in US$ Billion (Graphical Representation Included)
- Exhibit 3: Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
- Market Analysis by Geographic Region
- Analysis by Type
- Partial Parenteral Nutrition
  - Exhibit 4: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 5: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
- Total Parenteral Nutrition
  - Exhibit 6: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 7: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
- Analysis by Nutrients
- Carbohydrates
  - Exhibit 8: Carbohydrate Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 9: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific, Japan and Rest of World
- Salt and Electrolytes
  - Exhibit 10: Salt and Electrolytes Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 11: Salt and Electrolytes Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
- Minerals and Vitamins
  - Exhibit 12: Mineral and Vitamin Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 13: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
- Amino-Acids
  - Exhibit 14: Amino-Acid Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 15: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
- Other
  - Exhibit 16: Other Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  - Exhibit 17: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World
  - Exhibit 18: List of Major Global Companies
3. Regional Market Analysis
- North America
  - Exhibit 19: Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Major Companies in North America
  - Baxter International
  - Hospira, Inc
  - Analysis by Type
  - Partial Parenteral Nutrition
    - Exhibit 20: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 21: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region US and Canada (Graphical Representation Included)
  - Total Parenteral Nutrition
    - Exhibit 22: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 23: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  - Analysis by Nutrients
  - Carbohydrates
    - Exhibit 24: Carbohydrate Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 25: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  - Salt and Electrolytes
    - Exhibit 26: Salt and Electrolyte Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 27: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  - Minerals and Vitamins
    - Exhibit 28: Mineral and Vitamin Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 29: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  - Amino-Acids
    - Exhibit 30: Amino-Acid Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 31: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
  - Other
    - Exhibit 32: Other Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Geographic Region for US and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 33: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for US and Canada (Graphical Representation Included)
- Europe
  - Exhibit 34: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) in US$ Billion
  - Major Companies in Europe
  - B.Braun Melsungen AG
  - Fresenius Kabi AG
  - Groupe Danone
  - Laboratorios Grifols SA
  - Liqvor Pharmaceuticals
  - Nestle SA
  - Analysis by Type
  - Partial Parenteral Nutrition
    - Exhibit 35: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 36: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  - Total Parenteral Nutrition
    - Exhibit 37: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 38: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  - Analysis by Nutrients
  - Carbohydrates
    - Exhibit 39: Carbohydrate Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 40: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  - Salt and Electrolytes
    - Exhibit 41: Salt and Electrolyte Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 42: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  - Minerals and Vitamins
    - Exhibit 43: Mineral and Vitamin Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million
    - Exhibit 44: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  - Amino-Acids
    - Exhibit 45: Amino-Acid Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 46: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
  - Other
    - Exhibit 47: Other Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 48: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, France, United Kingdom, Switzerland, Russia and Rest of Europe
- Asia-Pacific
  - Exhibit 49: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  - Competitor Companies in Asia-Pacific
  - Ahlcon Parenterals India Ltd.
  - Ajinomoto Co., Inc
  - Amit Biotech
  - Baxter (India) Pvt. Ltd
  - Changzhou Huichun Medical Equipment Co., Ltd.
  - Claris Lifesciences Ltd.
  - Devson Impex Pvt., Ltd.
  - Divis Laboratories Ltd.
  - Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  - Hexagon Group
  - Ibis Chemie International
  - Jiangsu Jianquan Medical Devices Co., Ltd
  - Kelun Pharmaceutical Co., Ltd
  - Kyowa Hakko Kogyo Co., Ltd.
  - Marck Biosciences Ltd.
  - Molchemie Overseas Operations
  - Otsuka Pharmaceutical Co., Ltd
  - Priya Chemicals
  - Sino-Swed Pharmaceutical Corp., Ltd.
  - Terumo Corporation
  - Wuhan Amino Acid Bio-Chemical Co., Ltd
  - Wuhan University Hoyo Co., Ltd.
  - Analysis by Type
  - Partial Parenteral Nutrition
    - Exhibit 50: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 51: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  - Total Parenteral Nutrition
    - Exhibit 52: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 53: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  - Analysis by Nutrients
  - Carbohydrates
    - Exhibit 54: Carbohydrate Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 55: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  - Salt and Electrolytes
    - Exhibit 56: Salt and Electrolyte Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 57: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  - Minerals and Vitamins
    - Exhibit 58: Mineral and Vitamin Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 59: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  - Amino-Acids
    - Exhibit 60: Amino-Acid Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 61: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
  - Other
    - Exhibit 62: Other Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 63: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific
- Rest of World
  - Exhibit 64: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  - Gulf Inject LLC-A Rest of World Major Company
  - Analysis by Type
  - Partial Parenteral Nutrition
    - Exhibit 65: Intravenous Solutions for Partial Parenteral Nutrition (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 66: Intravenous Solutions for Partial Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
  - Total Parenteral Nutrition
    - Exhibit 67: Intravenous Solutions for Total Parenteral Nutrition (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 68: Intravenous Solutions for Total Parenteral Nutrition (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
  - Analysis by Nutrients
  - Catbohydrates
    - Exhibit 69: Carbohydrate Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 70: Carbohydrate Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
  - Salt and Electrolytes
    - Exhibit 71: Salt and Electrolyte Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 72: Salt and Electrolyte Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
  - Minerals and Vitamins
    - Exhibit 73: Mineral and Vitamin Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 74: Mineral and Vitamin Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
  - Amino-Acids
    - Exhibit 75: Amino-Acid Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 76: Amino-Acid Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World
  - Other
    - Exhibit 77: Other Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Geographic Region for Israel, Brazil and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 78: Other Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Israel, Brazil and Rest of World

III. PRODUCT TECHNOLOGY/RESEARCH

1. Introduction
- Intravenous Solutions
- Composition
- Application
- Types of Intravenous Solutions
- Large Volume Parenterals and Small Volume Parenteral
- Intravenous versus Oral Mode of Administration
- Risks
- Precautions
- Fat Emulsions
- Dextrose
- Plasma Expanders
- Cyclical Parenteral Nutrition
- Advantages of Cyclical Parenteral Nutrition
- Intravenous Solutions Growth Trends - Global Markets
  - Exhibit 79: Global Market for Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
  - Exhibit 80: Global Consumption of Intravenous Solutions
2. Segmentation of Intravenous Solutions
- Segmentation by Type
- Growth Trends - Global Market for Intravenous Solutions by Type
  - Exhibit 81: Global Market for Intravenous Solutions by Type (TPN and PPN) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Partial Parenteral Nutrition
- Growth Trends - Global Market of Intravenous Solutions for Partial Parenteral Nutrition
  - Exhibit 82: Global Market of Intravenous Solutions for Partial Parenteral Nutrition: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Total Parenteral Nutrition
- Growth Trends - Global Market of Intravenous Solutions for Total Parenteral Nutrition
  - Exhibit 83: Global Market of Intravenous Solutions for Total Parenteral Nutrition: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Total Parenteral Nutrition
- Complications
- Complications due to Catheter Insertion
- Metabolic Complications
- Segmentation by Nutrients
- Growth Trends - Global Market for Intravenous Solutions by Nutrients
  - Exhibit 84: Global Market for Intravenous Solutions by Nutrients (Other, Amino-Acids, Minerals & Vitamins, Salt & Electrolytes and Carbohydrates) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Carbohydrates
- Growth Trends - Global Market Carbohydrate Intravenous Solutions
  - Exhibit 85: Global Market for Carbohydrate Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Carbohydrates: Source of Nutrition
- Introduction
- Disadvantages of Over-feeding with the Carbon Source
- Endogenous Glucose Production and Oxidation
- Guidelines
- Glucose/Fat Ratio
- Salt and Elecrtolytes
- Growth Trends - Global Market for Salt and Electrolytes Intravenous Solutions
  - Exhibit 86: Global Market for Salt and Electrolytes Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Salt (Sodium chloride) and/ or Other Electrolytes
- Saline
- Concentrations
- Minerals and Vitamins
- Growth Trends - Global Market for Mineral and Vitamin Intravenous Solutions
  - Exhibit 87: Global Market for Mineral and Vitamin Intravenous Solutions: Geographic Regions (Rest of World, Asia-Pacific, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Minerals and Vitamins
- Amino-Acids
- Growth Trends - Global Market for Amino-Acid Intravenous Solutions
  - Exhibit 88: Global Market for Amino-Acid Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, North America and Europe) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Amino Acids and/or Protein Hydrolysates
- Dosage of Amino-Acid Solutions for Intravenous Use
- Other
- Growth Trends - Global Market for Other Intravenous Solutions
  - Exhibit 89: Global Market for Other Intravenous Solutions: Geographic Regions (Asia-Pacific, Rest of World, Europe and North America) Ranked by Projected CAGR for 2005 through 2013 (Graphical Representation Included)
- Fat (lipid) Emulsions
- Plasma Extenders
- Packaging and Identification Labeling of API' s and Intermediates
- General
- Packaging Materials
- Label Issuance and Control
- Packaging and Labeling Operations
- Storage and Distribution
- Warehousing Procedures
- Distribution Procedures
- Specific Guidance for API' s manufactured by Cell Culture/Fermentation
- General
- Cell Culture/Fermentation
- Harvesting, Isolation and Purification
- Viral Removal/Inactivation Steps
- Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices
- Safety Assessment Approach Used
- Conclusions of the Safety Assessment
- I V Infusion of Crystalloid Fluids and Drugs
- Total Parenteral Nutrition (TPN)
- Parenteral nutrition
- Government of India -Policy and Regulations on Drugs
- Drug Regulation and Control
- Maharashtra FDA: Latest Reforms
- Procedure for Drug Application in India
- Import and Manufacturing Licenses and Approvals
- Labeling Requirements
- Drug Price Regulation
- History of Drug Price Regulation
- Trends in Drug Price Control - India
- Regulations on Patent Protection
- Finale
- A Summary of the Chinese Pharmaceutical Market
- Consolidating the System - The State Drug Administration
- Pharmaceutical Regulations
- Pricing and Reimbursement
- Pharmaceutical Classification
- Registration
- Clinical Investigation
- Legal Reform: Intellectual Property Rights
- Conclusion
- Application of Knowledge and Skills Framework and its Review Procedure
- Introduction
- Decision to Form NHS KSF
- Purpose of Skills Framework
- Mode of Function
- Overview
- Distribution of Pharmaceutical Products

IV. MARKET DYNAMICS

1. Market Overview
- Economic Profile
- Market Growth Factors
- Global Market Analysis
  - Exhibit 90: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion(Graphical Representation Included)
  - Exhibit 91: Intravenous Solutions (2000, 2003 and 2005) - Percentage Breakdown of Global Market Value (Historic) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
  - Exhibit 92: Intravenous Solutions (2005-2013) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included)
  - Exhibit 93: Intravenous Solutions (2006, 2009 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)
- Analysis by Type
  - Exhibit 94: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
  - Exhibit 95: - Intravenous Solutions (2000, 2003 and 2005) - Percentage Breakdown of Global Market Value (Historic) by Type for PPN and TPN (Graphical Representation Included)
  - Exhibit 96: Intravenous Solutions (2005-2013) - Global Market Analysis (Current and Future) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
  - Exhibit 97: - Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Type for PPN and TPN (Graphical Representation Included)
- Analysis by Nutrients
  - Exhibit 98: Intravenous Solutions (2000-2006) - Global Market Analysis (Historic) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other in US$ Billion (Graphical Representation Included)
  - Exhibit 99: Intravenous Solutions (2000, 2003 and 2005) - Percentage Breakdown of Global Market Value (Historic) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino Acids and Other (Graphical Representation Included)
  - Exhibit 100: Intravenous Solutions (2005-2013) - Global Market Analysis (Current and Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
  - Exhibit 101: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Global Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
2. Major Global Companies in Intravenous Solutions Industry
- Ajinomoto Co., Inc. (Japan)
- B. Braun Melsungen AG (Germany)
- Baxter (India) Pvt. Ltd. (India)
- Baxter International (USA)
- Claris Lifesciences Ltd. (India)
- Fresenius Kabi (Germany)
- Gulf Inject LLC (UAE)
- Groupe Danone (France)
- Hospira, Inc (USA)
- Kelun Pharmaceutical Co., Ltd. (China)
- Kyowa Hakko Kogyo Co., Ltd. (Japan)
- Laboratorios Grifols (Spain)
- Liqvor Pharmaceuticals (Armenia)
- Marck Biosciences Ltd. (India)
- Nestle SA (Switzerland)
- Otsuka Pharmaceutical Co., Ltd. (Japan)
- Sino-Swed Pharmaceutical Corp., Ltd. (China)
- Terumo Corporation (Japan)
3. Competition Analysis
- Exhibit 102: Global Clinical Nutrition Market: 2007 Percentage Market Share by Major Companies (Graphical Representation Included)
- Exhibit 103: Global Intravenous Solution Products Market: 2007 Percentage Market Share by Major Companies (Graphical Representation Included)
- Exhibit 104: Major Companies in Intravenous Solutions Industry - Annual Sales for 2002 through 2006 in US$ Million
- Exhibit 105: Major Companies in Intravenous Solutions Industry - Production Volume and Capacity
4. Major Activities in Intravenous Solutions Industry
- Otsuka to Acquire Busulfex® IV from PDL BioPharma
- Hospira Obtains Marketing Authorization in the EU for Retacrit™
- Voluven - Product for Prevention & Treatment of Severe Blood Volume Loss following Surgery - Approved by the FDA.
- New Safety Packaging Introduced by Baxter Healthcare for High Alert Drugs
- Ajinomoto and Calpis in Integration Deal
- Transition to NextGen IV Immunoglobulin- Flebogamma® DIF - Concluded in record time in the US by Grifols
- Kyowa Hakko and Kirin Groups Formalize Strategic Alliance Agreement
- Baxter in Joint Venture with Guangzhou Baiyunshan for Parenteral Nutritional Products in China.
- EMEA Authorizes NextGen IVIG Distribution in European Union
- Kyowa Hakko Increases Amino Acid Prices in Europe
- Shanghai Century Acquisition Corporation Acquires the Shares of Sichuan Kelun Pharmaceutical Co., Ltd
- Advanced NutriSolutions Acquires Select Supplements from Kyowa Hakko
- Mayne Pharma Acquisition Process Completed by Hospira.
- Groupe Danone Acquires the Joint Venture Company - Calpis Ajinomoto Danone..
- FDA issues Marketing License to Grifols for NextGen Intravenous Immunoglobulin (IVIG) in the US
- Kyowa Hakko Releases White Paper Kit Attributed to Amino Acids and Related Compounds.
- Symbiq™ - The Next-Gen Infusion System from Hospira
- Health Alliance of Greater Cincinnati to Replace its Entire Fleet of IV Pumps Across Seven Hospitals
- Amigrand Intravenous Infusion Launched Jointly by Tanabe Seiyaku and Terumo.
- Systemic Fungal Infection Therapy AmBisome® 50 mg for Intravenous Drip Infusion - Launched
- Kyowa Hakko Launches Lumistor™
- The First Significantly Advanced Flexible IV Container in 3 decades..
- A New Line of Intravenous Solutions - AVIVA from Baxter.
- Cadence Pharmaceuticals Acquires Rights to IV APAP
- BioScrip Inc. Launches Specialty Infusion Operations on Western Coast by Acquiring Intravenous Therapy Services
- Boniva® - The First Intravenous Medication to treat Postmenopausal Osteoporosis, Approved by the FDA.
- Ajinomoto Acquires Amoy Food Group from Groupe Danone.
- FLEXBUMIN- the Flexible Container Packaged Albumin Solution from Baxter, Approved
5. Regional Market Analysis
- A. North America
  - Exhibit 106: Intravenous Solutions (2005-2013) -North American Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 107: List of Major Companies in North America
  - Analysis by Geographic Region
    - Exhibit 108: Intravenous Solutions (2005-2013) - North American Market Analysis (Current and Future) by Geographic Region for United States and Canada in US$ Billion (Graphical Representation Included)
    - Exhibit 109: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
  - Analysis by Type
    - Exhibit 110: Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
    - Exhibit 111: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 112: Intravenous Solutions (2005-2013) - North American Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
    - Exhibit 113: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of North American Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- A1. United States
  - Analysis by Type
    - Exhibit 114: Intravenous Solutions (2005-2013) - United States Market Analysis (Current & Future) by Type for PPN and TPN in US$ Billion (Graphical Representation Included)
    - Exhibit 115: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United States Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 116: Intravenous Solutions (2005-2013) - United States Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Billion (Graphical Representation Included)
    - Exhibit 117: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United States Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- A2. Canada
  - Analysis by Type
    - Exhibit 118: Intravenous Solutions (2005-2013) - Canadian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 119: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Canadian Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 120: Intravenous Solutions (2005-2013) - Canadian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 121: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Canadian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B. Europe
  - Exhibit 122: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) in US$ Billion (Graphical Representation Included)
  - Exhibit 123: List of Major Companies in Europe
  - Analysis by Geographic Region
    - Exhibit 124: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe in US$ Million (Graphical Representation Included)
    - Exhibit 125: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France, Switzerland and Rest of Europe
  - Analysis by Type
    - Exhibit 126: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 127: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 128: Intravenous Solutions (2005-2013) - European Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 129: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of European Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B1. Germany
  - Analysis by Type
    - Exhibit 130: Intravenous Solutions (2005-2013) - German Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 131: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of German Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 132: Intravenous Solutions (2005-2013) - German Market Analysis (Current &Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 133: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of German Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B2. France
  - Analysis by Type
    - Exhibit 134: Intravenous Solutions (2005-2013) - French Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 135: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of French Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 136: Intravenous Solutions (2005-2013) - French Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 137: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of French Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B3. United Kingdom
  - Analysis by Type
    - Exhibit 138: Intravenous Solutions (2005-2013) - United Kingdom Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 139: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United Kingdom Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 140: Intravenous Solutions (2005-2013) - United Kingdom Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 141: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of United Kingdom Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B4. Switzerland
  - Analysis by Type
    - Exhibit 142: Intravenous Solutions (2005-2013) - Swiss Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 143: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Swiss Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 144: Intravenous Solutions (2005-2013) - Swiss Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 145: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Swiss Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B5. Russia
  - Analysis by Type
    - Exhibit 146: Intravenous Solutions (2005-2013) - Russian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 147: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Russian Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 148: Intravenous Solutions (2005-2013) - Russian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 149: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Russian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- B6. Rest of Europe
  - Analysis by Type
    - Exhibit 150: Intravenous Solutions (2005-2013) - Rest of Europe Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 151: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Europe Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 152: Intravenous Solutions (2005-2013) - Rest of Europe Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 153: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Europe Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- C. Asia-Pacific
  - Exhibit 154: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  - Exhibit 155: List of Major Companies in Asia-Pacific
  - Analysis by Geographic Region
    - Exhibit 156: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
    - Exhibit 157: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for Japan, China, India, Australia and Rest of Asia-Pacific (Graphical Representation Included)
  - Analysis by Type
    - Exhibit 158: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 159: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 160: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 161: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- C1. Japan
  - Analysis by Type
    - Exhibit 162: Intravenous Solutions (2005-2013) - Japanese Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 163: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Japanese Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 164: Intravenous Solutions (2005-2013) - Japanese Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million
    - Exhibit 165: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Japanese Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- C2. China
  - Exhibit 166: Intravenous Solutions (2000-2013) - Chinese Volume Demand Analysis (Historic, Current and Future) in Billion Liters (Graphical Representation Included)
  - Analysis by Type
    - Exhibit 167: Intravenous Solutions (2005-2013) - Chinese Market Analysis (Historic, Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 168: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Chinese Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 169: Intravenous Solutions (2005-2013) - Chinese Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 170: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Chinese Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- C3. India
  - Exhibit 171: Intravenous Solutions (2000-2013) - Indian Volume Demand Analysis (Historic, Current & Future) in Billion Liters (Graphical Representation Included)
  - Analysis by Type
    - Exhibit 172: Intravenous Solutions (2005-2013) - Indian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 173: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Indian Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 174: Intravenous Solutions (2005-2013) - Indian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 175: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Indian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- C4. Australia
  - Analysis by Type
    - Exhibit 176: Intravenous Solutions (2005-2013) - Australian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 177: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Australian Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 178: Intravenous Solutions (2005-2013) - Australian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 179: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Australian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- C5. Rest of Asia-Pacific
  - Analysis by Type
    - Exhibit 180: Intravenous Solutions (2005-2013) - Rest of Asia-Pacific Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 181: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 182: Intravenous Solutions (2005-2013) - Rest of Asia-Pacific Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 183: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- D. Rest of World
  - Exhibit 184: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
  - Analysis by Geographic Region
    - Exhibit 185: Intravenous Solutions (2005-2013) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for Brazil, Israel and Rest of World in US$ Million (Graphical Representation Included)
    - Exhibit 186: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Brazil, Israel and Rest of World
  - Analysis by Type
    - Exhibit 187: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 188: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 189: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 190: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- D1. Brazil
  - Analysis by Type
    - Exhibit 191: Intravenous Solutions (2005-2013) - Brazilian Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 192: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Brazilian Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 193: Intravenous Solutions (2005-2013) - Brazilian Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 194: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Brazilian Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
- D2. Israel
  - Analysis by Type
    - Exhibit 195: Intravenous Solutions (2005-2013) - Israeli Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 196: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Israeli Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 197: Intravenous Solutions (2005-2013) - Israeli Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 198: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Israeli Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
  - Analysis by Type
    - Exhibit 199: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Type for PPN and TPN in US$ Million (Graphical Representation Included)
    - Exhibit 200: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Type for PPN and TPN (Graphical Representation Included)
  - Analysis by Nutrients
    - Exhibit 201: Intravenous Solutions (2005-2013) - Rest of World Market Analysis (Current & Future) by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other in US$ Million (Graphical Representation Included)
    - Exhibit 202: Intravenous Solutions (2006, 2010 and 2013) - Percentage Breakdown of Rest of World Market Value by Nutrients for Carbohydrates, Salt & Electrolytes, Minerals & Vitamins, Amino-Acids and Other
6. The Industry Outlook

V. CORPORATE DIRECTORY

[Report]

Intravenous Solutions - A MARKET INSIGHT REPORT

Published: 2008/03

Published by : RI Technologies

Price:

Product Code : RIT65879

Please inform me when related publications are released